Mark D. Hornstein, MD

About

Brigham and Women’s Hospital puts a specific physician on camera when it explains what IVF is for and how the cycle is done, and that physician is Mark D. Hornstein, MD. On the center’s own patient-education video he walks through the indications — historically blocked, damaged or absent fallopian tubes, now also endometriosis, uterine factors, ovulation failure, unexplained infertility and mild to moderate male factor — and the four mechanical steps from stimulation through transfer. Division directors are usually chosen for research and administrative weight. Being the person who delivers the explanation is a different signal: it means the institution treats him as the one who can make the tradeoffs in IVF legible to a patient.

He directs the reproductive endocrinology division at Brigham and Women’s and holds the Kosasa Family Endowed Chair in Obstetrics and Gynecology, with the rank of professor at Harvard Medical School. His own training took him from the University of Cincinnati College of Medicine, where he earned his MD in 1982, to Brigham and Women’s for internship, residency and a reproductive endocrinology and infertility fellowship completed in 1988. His listed clinical interests are the core medical and surgical triad of the field: assisted reproductive technology and IVF, infertility, and laparoscopic surgery.

That interest list also tells you what he does not advertise. There is no donor-egg or gestational-carrier program directorship in his profile and no fertility-surgery subspecialty title; those roles at this center belong to other physicians. What he covers is the IVF cycle itself and the laparoscopic work that frequently precedes it, and in his published views on program statistics he emphasizes the two figures patients should actually compare — live births per treatment cycle and the share of pregnancies involving triplets or more — rather than the raw pregnancy percentage.

Clinical Expertise

• IVF cycle management: Protocol design for stimulation, monitoring, retrieval under light anesthesia, and transfer at day 3 or day 5, with attention to the live-birth-per-cycle figure rather than the pregnancy rate.
• Indications counseling: Tubal disease, endometriosis, uterine and ovulatory factors, unexplained infertility, and mild to moderate male factor — including when IVF is the wrong next step.
• ICSI and laboratory technique: Single sperm injection where counts are very low or fertilization failed previously, plus assisted hatching for older patients, repeat implantation failure and thick zonae.
• Laparoscopic surgery: Minimally invasive treatment of endometriosis and tubal and pelvic disease through small incisions, in a department that also performs robotic myomectomy and tubal reversal.
• Cryopreservation decisions: Whether to freeze embryos now and transfer later, a choice Brigham’s own 2023 data leans toward — its frozen transfer live-birth rates ran above SART national averages in every age group while fresh cycle results fell below the national figure under 40.
• Multiple-pregnancy risk management: A stated program priority of maximizing pregnancy while minimizing triplets or higher, the metric he singles out in the center’s own success-rate discussion.

Why Choose Dr. Mark Hornstein

He sets the standard for the division. As reproductive endocrinology division director, the protocols, monitoring conventions and transfer policies used by the Brigham team are his responsibility, not one physician’s personal preference.

He is the institution’s IVF explainer. The center’s educational video on IVF indications and technique is presented by him, which is the closest thing a hospital publishes to a statement of how it thinks about patient consent.

Named by two independent lists, in the same year. Boston Magazine Top Doctor (2022) and Castle Connolly America’s Top Doctors (2022). Castle Connolly peer-nominates; neither is an outcome metric, and neither is a substitute for the SART figures, but the pair is a professional-recognition signal worth more than an awards badge on a clinic’s own website.

Four decades of cycles. Practicing since 1982, with postgraduate training entirely at Brigham and Women’s, and clinical appointments that let him see patients at Mass General Fertility in Boston and at the Mass General Brigham Reproductive Medicine Center on the Newton-Wellesley Hospital campus — useful if monitoring appointments need to happen closer to home.

Professional Affiliations

Professor at Harvard Medical School and Kosasa Family Endowed Chair in Obstetrics and Gynecology, directing the Reproductive Endocrinology Division at Brigham and Women’s Hospital. Certified by the American Board of Obstetrics and Gynecology in obstetrics and gynecology, with certification dates recorded in 1989 and 1990, following residency and reproductive endocrinology and infertility fellowship at Brigham and Women’s Hospital. Recognized as a Boston Magazine Top Doctor and in Castle Connolly America’s Top Doctors for 2022. His division operates inside a Center for Infertility and Reproductive Surgery that is a Society for Assisted Reproductive Technology member and reports results annually to the CDC. Appointments extend to Mass General Fertility and the Newton-Wellesley reproductive medicine service within the Mass General Brigham system.

Suitable For

• Couples at the decision point, not the treatment point: If you are unsure whether IVF is indicated for your diagnosis, this is the physician who explains the indications for a living.
• Mild to moderate male factor infertility: IVF where the sperm parameters do not automatically mandate donor sperm.
• Endometriosis and tubal disease patients: Those who may need laparoscopy before, or instead of, a stimulated cycle.
• Patients weighing fresh against frozen transfer: His own statistical framing favors looking at live birth per cycle and multiple-birth risk, which is the comparison that decides freeze-all strategies.
• Anyone who wants surgical backup in the same department: Brigham’s program performs robotic myomectomy, endometriosis excision and tubal reversal under the same faculty group.